Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets-Reference-Cited by-同舟云学术

Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets

Published:2019-08-19 Issue:11 Volume:15 Page:633-634
ISSN:1759-4790
Container-title:Nature Reviews Rheumatology
language:en
Short-container-title:Nat Rev Rheumatol

Author:

Aletaha Daniel,Smolen Josef S.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://www.nature.com/articles/s41584-019-0279-6.pdf

Reference10 articles.

1. Felson, D. T. et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann. Rheum. Dis. 70, 404–413 (2011).

2. Aletaha, D. & Smolen, J. S. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints. Arthritis Rheum. 63, 3702–3711 (2011).

3. Schoels, M. et al. Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition. Arthritis Res. Ther. 19, 155 (2017).

4. Linde, L. et al. Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important? 37, 285–290 (2010).

5. Thiele, K. et al. Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis. Ann. Rheum. Dis. 72, 1194–1199 (2013).

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-specific gene networks and drivers in rheumatoid arthritis synovial tissues;Frontiers in Immunology;2024-08-05

2. PH-sensitive BSA-modified resveratrol micelles targeting macrophages alleviate symptoms of rheumatoid arthritis;International Immunopharmacology;2024-07

3. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide;Reumatología Clínica;2024-07

4. DUSP6 deletion protects mice and reduces disease severity in autoimmune arthritis;iScience;2024-06

5. Correlation of US-7 and US-9 Scores with Disease Activity Score using 28 Joint Counts (DAS28) in Patients with Rheumatoid Arthritis;IRAN J MED SCI;2024